Does TORSEMIDE Cause Nephrogenic anaemia? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Nephrogenic anaemia have been filed in association with TORSEMIDE (Torsemide). This represents 0.1% of all adverse event reports for TORSEMIDE.
11
Reports of Nephrogenic anaemia with TORSEMIDE
0.1%
of all TORSEMIDE reports
0
Deaths
11
Hospitalizations
How Dangerous Is Nephrogenic anaemia From TORSEMIDE?
Of the 11 reports, 11 (100.0%) required hospitalization.
Is Nephrogenic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORSEMIDE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TORSEMIDE Cause?
General physical health deterioration (1,233)
Dyspnoea (1,176)
Acute kidney injury (975)
Dizziness (870)
Oedema peripheral (823)
Fall (707)
Dehydration (705)
Cardiac failure (698)
Hypotension (689)
Fatigue (635)
What Other Drugs Cause Nephrogenic anaemia?
OMEPRAZOLE (2,873)
ESOMEPRAZOLE (2,869)
LANSOPRAZOLE (2,162)
PANTOPRAZOLE (2,118)
DEXLANSOPRAZOLE (825)
RABEPRAZOLE (241)
ESOMEPRAZOLE\NAPROXEN (107)
OMEPRAZOLE\SODIUM BICARBONATE (94)
SODIUM, DIBASIC\SODIUM, MONOBASIC (91)
DAPRODUSTAT (40)
Which TORSEMIDE Alternatives Have Lower Nephrogenic anaemia Risk?
TORSEMIDE vs TOVIAZ
TORSEMIDE vs TOVORAFENIB
TORSEMIDE vs TOZINAMERAN
TORSEMIDE vs TRABECTEDIN
TORSEMIDE vs TRACLEER